Dr. LoBuono Specializes In Treating All Types of Skin Cancers

skin cancer screeningDid you know that Dr. LoBuono is a specialist in both general and surgical dermatology with respect to the treatment of all types of skin cancers, including melanomas, basal and squamous cell carcinomas, and Mycosis Fungoides (the most common form of cutaneous T-cell lymphoma which commonly affects the skin, but may progress internally)? Dr. LoBuono is board certified, with over 30 years of experience in private practice.

We talked about skin cancer in last month’s blog, but as a refresher, here are the three types of skin cancers, from least serious to most deadly:

  • Basal cell carcinomas are slow growing and are unlikely to spread or cause death.
  • Squamous cell carcinomas are more likely to spread. They, therefore, are more serious.
  • Melanomas are the most aggressive and the most serious.

Most skin cancers are manageable and easily treatable if caught early. The treatments can vary from “freezing” to surgical removal. If you have a growth that is surgically removed, Dr. LoBuono will send the removed tissue to a lab for testing and will then proceed with an appropriate treatment protocol.

One of the reasons it is so important to get yearly exams of your entire body, including your scalp, is to check for any changes to existing moles or growth and to scan for new growths. Melanoma is nothing to sneeze at and is not to be ignored. It can be deadly.

Summer is here and the sun is at its hottest. It goes without saying that using sunscreen is recommended as a preventative measure, as is wearing sunglasses to protect your eyes and wearing a hat, especially if you are balding. Remember also that the use of tanning beds has been linked to skin cancers.

The take-away is that we are here to help you with any concerns you may have, especially regarding skin cancer. Please don’t wait if you have a suspicious growth or a mole that has changed. Call to schedule an appointment with Dr. LoBuono, today: (732) 449-0167.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *